These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7224046)
21. Respiratory morbidity in late-preterm infants: prevention is better than cure! Jain L Am J Perinatol; 2008 Feb; 25(2):75-8. PubMed ID: 18214813 [No Abstract] [Full Text] [Related]
22. [Antenatal use of steroids in the prevention of respiratory distress syndrome in newborn infants]. Piganova NL; Nyrkova VI Akush Ginekol (Mosk); 1989 Jun; (6):9-12. PubMed ID: 2672855 [No Abstract] [Full Text] [Related]
23. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study]. Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029 [TBL] [Abstract][Full Text] [Related]
26. Benefit of antenatal glucocorticoids according to the cause of very premature birth. Foix-L'helias L; Baud O; Lenclen R; Kaminski M; Lacaze-Masmonteil T Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F46-8. PubMed ID: 15613573 [TBL] [Abstract][Full Text] [Related]
27. [The current status of inducing fetal lung maturity for prevention of neonatal respiratory distress syndrome]. Ragosch V; Weitzel H Gynakologe; 1995 Jun; 28(3):203-10. PubMed ID: 7657182 [No Abstract] [Full Text] [Related]
28. [A method of management of premature labor using glucocorticoids]. Ziółkowski K; Szymańska AD; Turowski J; Załucka K Ginekol Pol; 1985; 56(5-6):348-52. PubMed ID: 4054683 [No Abstract] [Full Text] [Related]
29. Corticosteroid treatment for prevention of prematurity complications. Celik C; Acar A; Cicek N; Koc H; Ak D; Akyurek C Arch Gynecol Obstet; 2002 Dec; 267(2):90-4. PubMed ID: 12439554 [TBL] [Abstract][Full Text] [Related]
30. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation. Smith LM; Qureshi N; Chao CR J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829 [TBL] [Abstract][Full Text] [Related]
31. [Prenatal prevention of the respiratory syndrome. I. Current status of knowledge]. Meriggi E; Parenti MR Minerva Ginecol; 1980 Mar; 32(3):175-86. PubMed ID: 6103524 [No Abstract] [Full Text] [Related]
32. ACOG Practice Bulletin No. 97: Fetal lung maturity. American College of Obstetricians and Gynecologists Obstet Gynecol; 2008 Sep; 112(3):717-26. PubMed ID: 18757686 [No Abstract] [Full Text] [Related]
33. The DART study of low-dose dexamethasone therapy. Rademaker KJ; Groenendaal F; van Bel F; de Vries LS; Uiterwaal CS Pediatrics; 2007 Sep; 120(3):689-90; author reply 690-1. PubMed ID: 17766548 [No Abstract] [Full Text] [Related]
34. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts. Zachman RD Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558 [No Abstract] [Full Text] [Related]
35. Antenatal dexamethasone and prevention of respiratory distress syndrome. Am J Obstet Gynecol; 1982 Sep; 144(1):113-4. PubMed ID: 7114100 [No Abstract] [Full Text] [Related]
36. Pharmacological approaches to the acceleration of fetal lung matturation. Avery ME Br Med Bull; 1975 Jan; 31(1):13-7. PubMed ID: 1180996 [No Abstract] [Full Text] [Related]
37. Management of the patient with premature rupture of the membranes. Mead PB Clin Perinatol; 1980 Sep; 7(2):243-55. PubMed ID: 7438666 [No Abstract] [Full Text] [Related]
38. Postnatal dexamethasone for lung disease of prematurity. Watchko JF; Brozanski BS N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218577 [No Abstract] [Full Text] [Related]
39. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis]. Driul L; Furlan R; Macagno F; Pezzani I; Plaino L; Ianni A; Casarsa S; Zavarise D; Marchesoni D Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841 [TBL] [Abstract][Full Text] [Related]